JN-302

N/A

Report date: 2024/04/29 14:58:51

Base Information

Drug NameJN-302
Drug Alias NameKB-302JN-302
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCollagen alpha-1(I) chain gene transference
TargetsCollagen alpha-1(I) chain
Therapy Area/IndicationsSkin Aging
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKrystal Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesJeune Inc
Inactive CompaniesN/A
Active IndicationsSkin Aging
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A